Sam Milstein

Analyst

Sam has been a consultant in the life sciences to Princeton Capital Management since its inception in 1988. He is currently President of Mortar & Pestle Consulting, a practice servicing financial and pharmaceutical companies. Previously, he was founder and CEO of Fulcrum Pharmaceuticals. He also served as President of Emisphere Technologies. Sam holds numerous patents on physico-chemical mechanisms for drug delivery. He was a chemistry major at City College of New York, and earned an M.S. in Physical Chemistry from University of New Brunswick and a PhD in Biochemistry from New York University.